Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment - Research Review - Final | AHRQ Effective Health Care Program

Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment - Research Review - Final | AHRQ Effective Health Care Program

Evidence Lacking on Benefits of Screening or Treating Early-Stage Chronic Kidney Disease

A new AHRQ research review found no or limited evidence that screening, monitoring, and treating adults with early-stage chronic kidney disease was beneficial to patients.  The condition affects more than 44 percent of U.S. adults over the age of 70.  The review examined screening, monitoring, and treatment of adults in stage 1, 2 or 3 of the five stages of chronic kidney disease.  Select to read Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment.

Research Review - Final – Jan. 31, 2012

Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment

Formats

• View PDF (PDF) 7.5 MB  
• Web Version (NLM Site)  

Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment - Research Review - Final | AHRQ Effective Health Care Program